3.93
-0.18(-4.38%)
Currency In USD
| Previous Close | 4.11 |
| Open | 4.38 |
| Day High | 4.49 |
| Day Low | 3.93 |
| 52-Week High | 1,134 |
| 52-Week Low | 3.88 |
| Volume | 64,436 |
| Average Volume | 318,477 |
| Market Cap | 2.27M |
| PE | -0.01 |
| EPS | -622.43 |
| Moving Average 50 Days | 12.28 |
| Moving Average 200 Days | 292.1 |
| Change | -0.18 |
Northstrive Biosciences Inc. Schedules Pre-IND Meeting with FDA for EL-22, an Obesity Therapy Targeting Fat Loss and Muscle Preservation in Combination with GLP-1
GlobeNewswire Inc.
Mar 10, 2025 12:00 PM GMT
Northstrive Biosciences Inc. has scheduled a pre-IND meeting with the U.S. Food and Drug Administration for April 23, 2025.EL-22 is leveraging a myostatin-engineered probiotic approach to address obesity’s pressing issue of preserving muscle while on
PMGC Holdings Inc. Announces Reverse Stock Split to Maintain Nasdaq Listing Compliance
GlobeNewswire Inc.
Mar 06, 2025 2:00 PM GMT
NEWPORT BEACH, Calif., March 06, 2025 (GLOBE NEWSWIRE) -- PMGC Holdings Inc. (NASDAQ: ELAB) (“PMGC” or the “Company”) today announced that it will effect a 1-for-7 reverse stock split (the “Split”) of its issued and outstanding common stock, par va
PMGC Holdings Inc. Expands Investment & M&A Efforts, Actively Seeking Acquisitions and Investments Through Strategic Sponsorship of TCA Venture Group
GlobeNewswire Inc.
Feb 27, 2025 1:00 PM GMT
NEWPORT BEACH, Calif., Feb. 27, 2025 (GLOBE NEWSWIRE) -- PMGC Holdings Inc. (the “Company” or “PMGC,” “our,” or “we”) (Nasdaq: ELAB), a diversified holding company, is proud to announce its annual sponsorship of TCA Venture Group’s (“TCA”) Orange C